See What HealthDay Can Do For You
Contact Us

Myo-inositol Levels Higher in Adults with Down Syndrome

Higher concentrations associated with reduced cognitive ability


FRIDAY, Dec. 9 (HealthDay News) -- Adults with Down syndrome have a higher concentration of myo-inositol in the hippocampus and this may predispose them to development of Alzheimer disease later in life, according to a study published in the December issue of the Archives of General Psychiatry. The transporter gene for myo-inositol, which affects neuron survival and function, is located on chromosome 21.

Declan G. M. Murphy, M.D., of the Institute of Psychiatry, London, and colleagues conducted a case-controlled study of 38 adults with Down syndrome without dementia and 42 healthy controls of similar age, ethnic origin, apolipoprotein E status and handedness.

The authors used the Cambridge Cognitive Examination to assess cognitive performance and also measured hippocampal myo-inositol concentration.

Among those with Down syndrome, hippocampal myo-inositol was significantly higher than among the controls, the investigators found. And there was a significant negative association between increased myo-inositol concentration and overall cognitive ability in those with Down syndrome.

"There is, at present, no treatment for cognitive impairment in Down syndrome. However, the possibility that increased myo-inositol concentration in the Down syndrome brain may be associated with a greater degree of mental retardation and/or later Alzheimer disease suggests that trials are required to determine whether reduction in brain myo-inositol concentration improves cognitive outcome in Down syndrome," the authors conclude.

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.